Why standard go-to-market processes break down for acquired products — and the interim "bridge" solutions that protect revenue while you figure it out.

What's on deck today:

• The hidden structural problems that typically create 12-18 month commercialization gaps for acquired products.
• Three real-world case studies — including one that triggered lawsuits and a projected 30-point market share decline.
• A framework for designing interim go-to-market processes that keep revenue flowing while integration catches up.
• A lightweight self-assessment to identify where your own acquired-product GTM has gaps.

The Going-Nowhere Deal Steerco Meeting

It's Month 6 post-close. The Target company's product you just acquired drove $40M in ARR at signing. The original deal thesis committed to 25% revenue growth in Year 1 through cross-sell into your existing customer base. Instead…

There's no sign of cross-sell revenue lift, and no alignment on how to get there:

• The sales team can't quote the acquired product, as it isn't in your ordering system.
• Pricing and incentives haven't been approved through your standard review process.
• Your deal desk team can't support contract negotiations and approvals, as the product can't be papered on your standard contract yet.
• The partner channel is clamoring to sell your newly-acquired product but isn't enabled within the partner program yet.
• And meanwhile the acquired company's customers are getting renewed - on terms and SLAs outside of your standard policies.

Your VP of Sales refuses to distract his teams with selling the acquired product … until product pricing and sales compensation models are established.

Your CFO wants to know ETA and confidence level for the missing synergies.

Your integration lead explains that before the new product can get into standard commercial operations, it must get approvals from the "NPI" (new product introduction) process — but is stuck behind five organically-developed products already in the launch queue.

Your standard NPI process might be solid, but it isn't designed to handle M&A scenarios.

This is one of the most common — and least understood — failure points in M&A. A structural mismatch and gap between acquirers' standard procedures for commercializing products and how acquired products need to be handled (and the off-cycle urgency typically attached to deal projects, that falls outside the normal rhythm of NPI reviews).

The Problem: Your NPI Process Wasn't Built for "AQPI"

McKinsey's recent analysis of 248 large deals found that 79% of deals outperforming at 18 months continued outperforming at three years — but only 17% of underperformers at that mark ever recovered. The first 12-18 months are so important, they're deterministic. And for acquired products, this window is exactly when the commercialization gap creates ROI blockers.

Every large company has some form of New Product Introduction process (NPI). It's how products move from concept through development to commercial readiness — a series of reviews for getting pricing approved, SKUs created, sales teams enabled, partner programs aligned, and support models vetted.

These processes assume the product is being built from scratch. Sequential phases. Tollgates. Cross-functional reviews designed around a product that doesn't exist in the market yet.

But acquired products arrive with most of that scope already established — but in a way that often isn't compatible with the acquirer's standards. They have existing customers expecting uninterrupted service, on terms your company wouldn't normally commit to (or at worst, represent material risk). The Target company's pricing, Support SLAs, and even licensing model (subscription, consumption, etc) may be misaligned with your policies or your deal objectives. Go-to-market motions may look nothing like how you as the acquirer sell. All of these legacy commercial terms may be urgent to transition away from, yet customer migration is sensitive and determining what terms to transition TO may take time.

So pushing acquired products through your standard NPI queue creates a brutal choice:

1. Pause on new sales of the acquired product until it's "NPI approved" for a standardized launch, meanwhile supporting existing TargetCo customers. The product sits in a GTM limbo for several months while it waits its turn, requiring postponement of your acquisition's cross-selling synergy timeline.
2. Or, proceed with the original cross-selling initiative, and address the pre-NPI-approval period through semi-manual "bridge process" workarounds that temporarily satisfy Sales' prerequisites and new-customer experience requirements. This requires additional investment in resources to implement and temporarily support the bridge processes – and alignment with relevant leadership on the approach.

What This Looks Like in Practice

Broadcom/VMware: Ripping Off the Band-Aid (and the Skin Underneath)

When Broadcom closed its $61 billion VMware acquisition in November 2023, it didn't just integrate VMware's products — it overhauled the entire commercial model simultaneously. Perpetual licenses eliminated. Subscription-only licensing mandated. Roughly 8,000 SKUs collapsed into four bundles. And VMware's Partner Connect program — approximately 28,000 channel partners — was terminated and replaced with an invitation-only model.

The pricing shock was severe. Industry reports documented increases ranging from 150% to over 1,200%. AT&T faced a proposed 1,050% annual increase. A British university saw projected costs rise from £40,000 to £500,000. A Canalys poll found 70% of VMware partners actively looking to leave.

The short-term financial results were impressive — VMware operating margins leapt from 13-22% pre-acquisition to 77%. But Gartner projects VMware's market share will fall from 70% to 40% by 2029. Legal action proliferated from AT&T, UnitedHealthcare, Fidelity, and European cloud providers. Two years post-close, Broadcom acknowledged they're only "more than halfway" through the renewal cycle.

The lesson isn't that commercial model changes are wrong — sometimes they're necessary. The lesson is that changing pricing, packaging, licensing, and channel strategy simultaneously, without interim bridge processes, creates a shock wave that can permanently impair the commercial franchise you paid $61 billion for.

Oracle/Cerner: When the Customer-Facing Team Disappears

Oracle's $28.3 billion Cerner acquisition tells a different cautionary tale. Oracle didn't deliberately blow up the commercial model — it blew up the organization that maintained it. After rebranding to Oracle Health, Oracle closed Cerner's Kansas City campus and reduced the division's workforce by approximately 50%, cutting more than 3,000 from consulting and sales alone between March 2023 and February 2024.

The customer impact was devastating. KLAS Research documented accelerating departures: 4,658 beds lost in 2022, 15,392 beds in 2023 (the largest net hospital loss on record), and 17,232 beds in 2024. In total, 57 unique acute care customers departed in three years. Oracle Health's market share declined from 25% to 22.9% while competitor Epic grew to 42.3%.

By 2024, half of interviewed Oracle Health customers told KLAS they would not purchase the EHR again. Oracle's announcement of a "completely new EHR platform" effectively conceded that the integration had failed.

The bridge lesson: Even when you're not changing the commercial model, gutting the acquired organization's customer-facing capabilities — the people who know the customers, understand the product, and maintain the relationships — triggers a doom loop of declining satisfaction and accelerating churn. Acquired product GTM isn't just systems and processes. It's people.

Cisco/Duo: The 14-Month Ordering Gap

Cisco's acquisition history reveals the most instructive structural pattern. When Cisco acquired Duo Security for $2.35 billion in October 2018, it took 14 months before Duo products appeared on Cisco's Global Price List and could be quoted through Cisco Commerce Workspace. For that entire period, legacy Duo customers and partners used Duo's own ordering processes — a fully parallel commercial system.

This wasn't an anomaly. AppDynamics ran its own independent partner program with separate tiers. ThousandEyes maintained dual support systems. The pattern repeated because enterprise ordering systems, pricing engines, and partner programs are designed for products born inside the company, not for rapidly onboarding external products with existing customers and channel relationships.

Cisco has since tried to break this pattern. With the $28 billion Splunk acquisition in 2024, Splunk was placed on Cisco's price list early, a cross-sell program targeting 5,000 Cisco customers was launched, and a dedicated Sales Acceleration Office was created. But even with that deliberate effort, the partner program merger won't complete until February 2026 — nearly two years post-close. Progress, not perfection.

The Fix: Bridge Processes That Keep Revenue Flowing

The pattern across these cases is clear: acquired products need an interim commercial path — a "bridge" — that maintains revenue continuity while the longer-term systems integration happens in the background.

At Tiger Team M&A, we've built bridge workflows into our M&AOP framework specifically because we kept seeing this problem destroy deal value at Fortune 100 acquirers. The concept isn't complicated, but the execution requires deliberate cross-functional coordination that most organizations don't plan for.

A bridge process answers four questions that standard NPI can't:

1. How do we keep selling the acquired product today? Define the interim selling motion — who can quote it, through what systems, with what approvals. This might mean maintaining the acquired company's billing systems for 6-12 months while quote-to-cash integration happens. It might mean a manual deal desk process for the first 90 days. The specific mechanism matters less than having a defined, sanctioned path that doesn't require sales reps to invent workarounds.

2. What interim governance is appropriate? Not all acquired products need the same level of scrutiny. A product with standard SaaS pricing that fits existing billing models is different from one with custom enterprise contracts and non-standard revenue recognition. Tiering the review process — express track for simple cases, full cross-functional review for complex ones — prevents bottlenecks without sacrificing governance.

3. Who owns what during the interim period? The biggest source of friction is ambiguity. Is the acquired product's pricing owned by the legacy team or the acquirer's pricing function? Who handles renewals? Who approves exceptions? A clear RACI with the M&A function serving as shepherd eliminates the "I thought you were handling that" conversations that kill momentum.

4. When does the bridge end? Every interim process needs defined sunset criteria — specific milestones (systems integration complete, SKUs live in ordering system, sales enablement delivered) that trigger the transition from bridge to standard operations. Without these, bridge processes become permanent workarounds that compound operational complexity over time.

The best recent example of bridge thinking in action is Palo Alto Networks' acquisition of IBM's QRadar SaaS assets. Rather than forcing immediate migration, Palo Alto and IBM designed a joint transition: QRadar customers continued on current deployments with uninterrupted service, IBM trained over 1,000 consultants on Palo Alto solutions, and qualified customers received free migration services. The result? Roughly one-third of Palo Alto's 70-plus new "platformization" deals in Q1 FY2025 came from IBM QRadar migrations — turning the acquired customer base into an immediate growth driver rather than an integration liability.

That's what a well-designed bridge does. It converts a potential value-destruction period into a value-creation runway.

Quick Self-Assessment: Is Your Acquired Product GTM Exposed?

If you're in the middle of — or planning — an acquisition involving an existing product with customers, ask yourself these five questions:

• Can your sales team quote and close the acquired product today through your standard systems? If not, is there a defined interim process — or are they improvising?
• Do acquired product customers know who to call for renewals, support, and escalations? Or are they navigating organizational ambiguity?
• Is someone explicitly accountable for acquired product revenue during the integration period — not just integration milestones, but actual commercial performance?
• Does your NPI process have an acquired-product track — or is the acquired product in the same queue as products being built from scratch?
• Have you defined when the interim state ends — specific criteria that trigger the transition to standard operations?

If you answered "no" or "I'm not sure" to two or more of these, you're likely experiencing (or about to experience) the commercialization gap. And the clock started the day the deal closed.

The Bottom Line

The acquired product's revenue stream is the asset you paid for. Every day that product can't be sold through your channels — or your existing customers can't be served without friction — is a day of value destruction.

Most acquirers treat commercial integration as a downstream consequence of IT systems integration and organizational design. The companies that protect deal value treat it as the primary activity that should drive the integration plan from Day 1.

Bridge processes aren't a permanent solution. They're the difference between 12-18 months of commercial momentum and 12-18 months of commercial paralysis while you wait for the "real" systems to be ready.

To address exactly this need, we incorporated bridge workflows and acquired product integration (AQPI) solutioning into our M&AOP framework — because the gap between deal close and commercial readiness is where we've seen more deal value evaporate than almost anywhere else in the M&A lifecycle.